A pioglitazon antiatheroscleroticus hatása elso bizonyí ték a triglicerid/HDL arány szerepére

Translated title of the contribution: Anti-atherosclerotic effect of pioglitazone - the first evidence of the role of triglyceride/HDL ratio

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The presence of multiple risk factors can multiply exponentially the risk of cardiovascular events, thus cardiovascular diseases are more severe in diabetes mellitus. One of the challenges we face today is the application of drugs that, besides improving glucose homeostasis, also have antiatherosclerotic effect. Such candidates are glitazones, which have pleiotropic efficiency beyond their main effect: they improve distribution of adipose tissue, blood pressure and endothelial function and also have anti-inflammatory and anti-coagulation capacity.Regarding the effects on lipid metabolism, there are differences between various glitazones: improvements are mainly achieved by pioglitazone, which markedly reduces triglyceride levels, and also elevates HDL levels and decreases the ratio of small, dense LDL-particles.Studies on clinical outcomes also show the superiority of pioglitazone. Imaging of blood vessels (carotis-IMT, intracoronary ultrasound technique) also suggest a greater efficiency of pioglitazone. According to the latest analysis of the PERISCOPE study, the stability of the coronary plaque was associated only with the triglyceride/ HDL ratio in case of pioglitazone. The newest data also revealed that pioglitazone uniquely increases the cholesterol-efflux attributed to HDL-related macrophages. On the basis of the latest results, pioglitazone not only improves glucose homeostasis, but also has a remarkable anti-atherosclerotic effect, which is primarily due to its favourable lipid metabolism profile.

Translated title of the contributionAnti-atherosclerotic effect of pioglitazone - the first evidence of the role of triglyceride/HDL ratio
Original languageHungarian
Pages (from-to)105-111
Number of pages7
JournalLege Artis Medicinae
Volume21
Issue number2
Publication statusPublished - Feb 1 2011

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Anti-atherosclerotic effect of pioglitazone - the first evidence of the role of triglyceride/HDL ratio'. Together they form a unique fingerprint.

  • Cite this